El tratamiento oportuno de personas con COVID-19 busca minimizar el número de
complicaciones y muertes por esta enfermedad. Por ello, el Seguro Social de Salud del Perú
(EsSalud) priorizó la realización de la presente guía de práctica clínica (GPC) con la finalidad de
establecer recomendaciones ba...
Salinas, Ariel;
Huaringa-Marcelo, Jorge;
Alfaro-Lozano, José;
Becerra-Chauca, Naysha;
Nieto-Gutierre, Wendy;
Garcia-Gomero, David;
De la Jara, Jesús;
Calderón-Gallegos, Julia;
Flores, Cesar;
Taype-Rondan, Alvaro;
Timaná-Ruiz, Raúl;
Salvador-Salvador, Stefany;
Carrera-Acosta, Lourdes;
Gamboa-Cárdenas, Rocío.
La Artritis Reumatoide (AR) tiene adversas consecuencias en la salud su diagnóstico temprano y manejo óptimo requiere recomendaciones basadas en evidencia de alta calidad adaptadas a cada sistema de salud. Objetivo: Proveer recomendaciones clínicas basadas en evidencia para el diagnóstico y manejo in...
Primary immune thrombocytopenia (ITP) is the most common cause of thrombocytopenia in children, with a reported incidence of 1.1-12.5 cases per 100 000 children. However, currently, there are several definitions of ITP, as well as diagnostic and therapeutic approaches. To develop an evidence-based clinic...
Purpura, Thrombocytopenic, Idiopathic/drug therapy,
Immunoglobulins, Intravenous/therapeutic use,
Adrenal Cortex Hormones/therapeutic use,
Receptors, Thrombopoietin/therapeutic use,
Purpura, Thrombocytopenic, Idiopathic/diagnosis
This guideline covers diagnosing and managing bronchiolitis in babies and children. It aims to help
healthcare professionals diagnose bronchiolitis and identify if babies and children should be cared
for at home or in hospital. It describes treatments and interventions that can be used to help with
the s...
Fernandez, Evans Perez;
Travis, William;
Lynch, David;
Brown, Kevin;
Johannson, Kerri;
Selman, Moises;
Ryu, Jay;
Wells, Athol;
Huang, Yuh-Chin;
Pereira, Carlos;
Scholand, Mary-Beth;
Villar, Ana;
Inase, Naohiko;
Evans, Richard;
Mette, Stephen;
Frazer-Green, Lindsy.
The purpose of this analysis is to provide evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variability. Approved panelists developed key questions regarding the diagnosis o...
Perez Fernandez, Evans;
Travis, William;
Lynch, David;
Brown, Kevin;
Johannson, Kerri;
Selman, Moises;
Ryu, Jay;
Wells, Athol;
Huang, Yuh-Chin;
Pereira, Carlos;
Scholand, Mary-Beth;
Villar, Ana;
Inase, Naohiko;
Evans, Richard;
Mette, Stephen;
Frazer-Green, Lindsy.
The purpose of this analysis is to provide evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variability. Approved panelists developed key questions regarding the diagnosis o...
Soler-Cataluñaa, Juan José;
Piñera, Pascual;
Trigueros, Juan Antonio;
Calle, Myriam;
Casanova, Ciro;
Cosío, Borja G;
López-Campos, José Luis;
Molina, Jesús;
Almagro, Pere;
Gómez, José-Tomás;
Riesco, Juan Antonio;
Simonetm, Pere;
Rigaun, David;
Soriano, Joan B;
Ancochea, Julio;
Miravitlles, Marc.
En este artículo se presentan las recomendaciones sobre el diagnóstico y tratamiento del síndrome de agudización de la enfermedad pulmonar obstructiva crónica (EPOC) (SAE) de GesEPOC 2021. Como principales novedades, la guía propone una definición y aproximación sindrómica, una nueva clasificaci...
Miravitlles, Marc;
Calle, Myriam;
Molina, Jesús;
Almagro, Pere;
Gómez, José-Tomás;
Trigueros, Juan Antonio;
Cosío, Borja G;
Casanova, Ciro;
López-Camposb, José Luis;
Riescob, Juan Antonio;
Simonetl, Pere;
Rigau, David;
Soriano, Joan B;
Ancochea, Julio;
Soler-Cataluña, Juan José.
The Spanish COPD Guidelines (GesEPOC) were first published in 2012, and since then have undergone a series of updates incorporating new evidence on the diagnosis and treatment of COPD. GesEPOC was drawn up in partnership with scientific societies involved in the treatment of COPD and the Spanish Patients...
This guideline covers assessing all chronic pain (chronic primary pain, chronic secondary pain, or both) and managing chronic primary pain in people aged 16 years and over. Chronic primary pain is pain with no clear underlying cause, or pain (or its impact) that is out of proportion to any observable inj...
Chronic Pain/classification,
Chronic Pain/drug therapy,
Chronic Pain/prevention & control,
Antidepressive Agents/therapeutic use,
Medical Marijuana/therapeutic use,
Analgesics, Opioid/therapeutic use,
Benzodiazepines/therapeutic use,
Anticonvulsants/therapeutic use,
Anesthetics, Local/therapeutic use,
Adrenal Cortex Hormones/therapeutic use,
Acupuncture Therapy
This guideline covers diagnosing, monitoring and managing asthma in adults, young people and
children. It aims to improve the accuracy of diagnosis, help people to control their asthma and
reduce the risk of asthma attacks. It does not cover managing severe asthma or acute asthma
attacks.
In March 2021, ...
